TempraMed Technologies Ltd., a medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products. Its primary focus is storage and management of injectable for temperatu…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-29
Interim MD&A - English.pdf
Results 2026-05-29
Interim financial statements/report – English.pdf
News 2026-05-14
TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart Product
News release - English.pdf
Results 2026-04-30
Annual MD&A - English.pdf
Results 2026-04-30
Audited annual financial statements – English.pdf
Ownership 2026-04-29
Other securityholders documents - English.pdf
News 2026-04-07
TempraMed Announces Additional Granted Brazilian Patent for Newest VIVI Box Product
News release - English.pdf
Transactions 2026-03-30 M&A
TempraMed Signs LOI for Distribution Agreement in Panama, Expanding Central American Exposure
News release - English.pdf
News 2026-03-24
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
News release - English.pdf
News 2026-03-17
Other.pdf
News 2026-03-11
TempraMed's Independently Validated Payer ROI Model for Reimbursement Further Reinforced by a Scientific Publication Highlighting Clinical and Economic Rationale for VIVI Cap
News release - English.pdf
News 2026-02-26
TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States
News release - English.pdf
News 2026-02-10
TempraMed Partners with Super-Pharm, Israel's Leading Pharmacy Chain to Commence a National Product Roll Out Strategy
News release - English.pdf
News 2026-02-06
TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel
News release - English.pdf
News 2026-02-02
TempraMed Enters Strategic Media Partnership with Dr. Phil's Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States
News release - English.pdf
News 2026-01-23
TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
News release - English.pdf
News 2026-01-23
Report of exempt distribution (45-106F1).pdf
News 2026-01-14
TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage
News release - English.pdf
Transactions 2026-01-12 Financing
TempraMed Closes C$2.5 Million Fully Subscribed Private Placement
News release - English.pdf
News 2026-01-06
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network
News release - English.pdf
Results 2026-01-02
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026
News release - English.pdf
News 2025-12-31
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea
News release - English.pdf
News 2025-12-26
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering
News release - English.pdf
News 2025-12-17
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
News release - English.pdf
News 2025-12-15
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent
News release - English.pdf
News 2025-12-08
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
News release - English.pdf
News 2025-12-05
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
News release - English.pdf
News 2025-12-02
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
News release - English.pdf
News 2025-11-26
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
News release - English.pdf
Results 2025-11-26 Financials
Interim MD&A - English.pdf
Results 2025-11-26 Financials
Interim financial statements/report – English.pdf
News 2025-11-20
Other.pdf
News 2025-11-20
Code of conduct.pdf
News 2025-11-20
Other.pdf
Transactions 2025-11-12
Other material contracts - English.pdf
News 2025-10-27
News release - English.pdf
News 2025-10-25
Material change report - English.pdf
News 2025-10-21
News release - English.pdf
News 2025-10-15
News release - English.pdf
News 2025-10-14
Filing statement - English.pdf
News 2025-10-10
Early warning report.pdf
News 2025-10-10
Press release - English.pdf
News 2025-10-10
Material change report - English.pdf
News 2025-10-10
Escrow agreement.pdf
News 2025-10-10
News release - English.pdf
News 2025-10-07
Report of exempt distribution (45-106F1) (amended).pdf
News 2025-09-29
Final Receipt.pdf
Transactions 2025-09-27 Financing
Final long form prospectus - English.pdf
Transactions 2025-09-25 Financing
Other material contract(s).pdf
Transactions 2025-09-25 Financing
Other material contract(s).pdf
Transactions 2025-09-25 Financing
Other material contract(s).pdf
Transactions 2025-09-25 Financing
Other material contract(s).pdf
Transactions 2025-09-25 Financing
Other material contract(s).pdf
Transactions 2025-09-25 Financing
Other material contract(s).pdf
News 2025-09-19
Report of exempt distribution (45-106F1).pdf
News 2025-09-19
Certificate and articles of change of name.pdf
News 2025-09-19
Certificate and articles of change of name.pdf
News 2025-09-19
Certificate and articles of change of name.pdf
Transactions 2025-07-31 Financing
Receipt for Amendment to Preliminary Prospectus.pdf
Transactions 2025-07-31
Receipt for Amendment to Preliminary Prospectus.pdf
Transactions 2025-07-31 Financing
Amendment to (or amended) preliminary long form prospectus - English.pdf
Transactions 2025-07-31
Amendment to (or amended) preliminary long form prospectus - English.pdf